BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 38062485)

  • 1. Novel data-driven subtypes and stages of brain atrophy in the ALS-FTD spectrum.
    Shen T; Vogel JW; Duda J; Phillips JS; Cook PA; Gee J; Elman L; Quinn C; Amado DA; Baer M; Massimo L; Grossman M; Irwin DJ; McMillan CT
    Transl Neurodegener; 2023 Dec; 12(1):57. PubMed ID: 38062485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel data-driven subtypes and stages of brain atrophy in the ALS-FTD spectrum.
    Shen T; Vogel JW; Duda J; Phillips JS; Cook PA; Gee J; Elman L; Quinn C; Amado DA; Baer M; Massimo L; Grossman M; Irwin DJ; McMillan CT
    Res Sq; 2023 Aug; ():. PubMed ID: 37609205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Data-driven neuropathological staging and subtyping of TDP-43 proteinopathies.
    Young AL; Vogel JW; Robinson JL; McMillan CT; Ossenkoppele R; Wolk DA; Irwin DJ; Elman L; Grossman M; Lee VMY; Lee EB; Hansson O
    Brain; 2023 Jul; 146(7):2975-2988. PubMed ID: 37150879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and neuropathologic heterogeneity of c9FTD/ALS associated with hexanucleotide repeat expansion in C9ORF72.
    Murray ME; DeJesus-Hernandez M; Rutherford NJ; Baker M; Duara R; Graff-Radford NR; Wszolek ZK; Ferman TJ; Josephs KA; Boylan KB; Rademakers R; Dickson DW
    Acta Neuropathol; 2011 Dec; 122(6):673-90. PubMed ID: 22083254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and neuropathological features of ALS/FTD with TIA1 mutations.
    Hirsch-Reinshagen V; Pottier C; Nicholson AM; Baker M; Hsiung GR; Krieger C; Sengdy P; Boylan KB; Dickson DW; Mesulam M; Weintraub S; Bigio E; Zinman L; Keith J; Rogaeva E; Zivkovic SA; Lacomis D; Taylor JP; Rademakers R; Mackenzie IRA
    Acta Neuropathol Commun; 2017 Dec; 5(1):96. PubMed ID: 29216908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal imaging in
    Floeter MK; Bageac D; Danielian LE; Braun LE; Traynor BJ; Kwan JY
    Neuroimage Clin; 2016; 12():1035-1043. PubMed ID: 27995069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The involvement of language-associated networks, tracts, and cortical regions in frontotemporal dementia and amyotrophic lateral sclerosis: Structural and functional alterations.
    Tahedl M; Tan EL; Chipika RH; Lope J; Hengeveld JC; Doherty MA; McLaughlin RL; Hardiman O; Hutchinson S; McKenna MC; Bede P
    Brain Behav; 2023 Nov; 13(11):e3250. PubMed ID: 37694825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneity of cortical pTDP-43 inclusion morphologies in amyotrophic lateral sclerosis.
    Tan RH; McCann H; Shepherd CE; Pinkerton M; Mazumder S; Devenney EM; Adler GL; Rowe DB; Kril J; Halliday GM; Kiernan MC
    Acta Neuropathol Commun; 2023 Nov; 11(1):180. PubMed ID: 37957721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frontotemporal dementia due to C9ORF72 mutations: clinical and imaging features.
    Sha SJ; Takada LT; Rankin KP; Yokoyama JS; Rutherford NJ; Fong JC; Khan B; Karydas A; Baker MC; DeJesus-Hernandez M; Pribadi M; Coppola G; Geschwind DH; Rademakers R; Lee SE; Seeley W; Miller BL; Boxer AL
    Neurology; 2012 Sep; 79(10):1002-11. PubMed ID: 22875087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A proteomic network approach across the ALS-FTD disease spectrum resolves clinical phenotypes and genetic vulnerability in human brain.
    Umoh ME; Dammer EB; Dai J; Duong DM; Lah JJ; Levey AI; Gearing M; Glass JD; Seyfried NT
    EMBO Mol Med; 2018 Jan; 10(1):48-62. PubMed ID: 29191947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SQSTM1 variant in disorders of the frontotemporal dementia-amyotrophic lateral sclerosis spectrum: identification of a novel heterozygous variant and a review of the literature.
    Li W; Gao H; Dong X; Zheng D
    J Neurol; 2021 Apr; 268(4):1351-1357. PubMed ID: 33125541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum total TDP-43 levels are decreased in frontotemporal dementia patients with C9orf72 repeat expansion or concomitant motoneuron disease phenotype.
    Katisko K; Huber N; Kokkola T; Hartikainen P; Krüger J; Heikkinen AL; Paananen V; Leinonen V; Korhonen VE; Helisalmi S; Herukka SK; Cantoni V; Gadola Y; Archetti S; Remes AM; Haapasalo A; Borroni B; Solje E
    Alzheimers Res Ther; 2022 Oct; 14(1):151. PubMed ID: 36217158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective Genetic Overlap Between Amyotrophic Lateral Sclerosis and Diseases of the Frontotemporal Dementia Spectrum.
    Karch CM; Wen N; Fan CC; Yokoyama JS; Kouri N; Ross OA; Höglinger G; Müller U; Ferrari R; Hardy J; Schellenberg GD; Sleiman PM; Momeni P; Hess CP; Miller BL; Sharma M; Van Deerlin V; Smeland OB; Andreassen OA; Dale AM; Desikan RS;
    JAMA Neurol; 2018 Jul; 75(7):860-875. PubMed ID: 29630712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysosome dysfunction as a cause of neurodegenerative diseases: Lessons from frontotemporal dementia and amyotrophic lateral sclerosis.
    Root J; Merino P; Nuckols A; Johnson M; Kukar T
    Neurobiol Dis; 2021 Jul; 154():105360. PubMed ID: 33812000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C9orf72 and UNC13A are shared risk loci for amyotrophic lateral sclerosis and frontotemporal dementia: a genome-wide meta-analysis.
    Diekstra FP; Van Deerlin VM; van Swieten JC; Al-Chalabi A; Ludolph AC; Weishaupt JH; Hardiman O; Landers JE; Brown RH; van Es MA; Pasterkamp RJ; Koppers M; Andersen PM; Estrada K; Rivadeneira F; Hofman A; Uitterlinden AG; van Damme P; Melki J; Meininger V; Shatunov A; Shaw CE; Leigh PN; Shaw PJ; Morrison KE; Fogh I; Chiò A; Traynor BJ; Czell D; Weber M; Heutink P; de Bakker PI; Silani V; Robberecht W; van den Berg LH; Veldink JH
    Ann Neurol; 2014 Jul; 76(1):120-33. PubMed ID: 24931836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The emerging roles of microRNAs in the pathogenesis of frontotemporal dementia-amyotrophic lateral sclerosis (FTD-ALS) spectrum disorders.
    Gascon E; Gao FB
    J Neurogenet; 2014; 28(1-2):30-40. PubMed ID: 24506814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel
    Lamb R; Rohrer JD; Real R; Lubbe SJ; Waite AJ; Blake DJ; Walters RJ; Lashley T; Revesz T; Holton JL; Morris HR
    Cold Spring Harb Mol Case Stud; 2019 Jun; 5(3):. PubMed ID: 31160356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical, neuroimaging and neuropathological features of a new chromosome 9p-linked FTD-ALS family.
    Boxer AL; Mackenzie IR; Boeve BF; Baker M; Seeley WW; Crook R; Feldman H; Hsiung GY; Rutherford N; Laluz V; Whitwell J; Foti D; McDade E; Molano J; Karydas A; Wojtas A; Goldman J; Mirsky J; Sengdy P; Dearmond S; Miller BL; Rademakers R
    J Neurol Neurosurg Psychiatry; 2011 Feb; 82(2):196-203. PubMed ID: 20562461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain structural and perfusion changes in amyotrophic lateral sclerosis-frontotemporal dementia patients with cognitive and motor onset: a preliminary study.
    Wang Y; Shen D; Hou B; Sun X; Yang X; Gao J; Liu M; Feng F; Cui L
    Brain Imaging Behav; 2022 Oct; 16(5):2164-2174. PubMed ID: 35838935
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.